Fintel reports that on April 7, 2025, HC Wainwright & Co. initiated coverage of Fold Holdings (NasdaqCM:FLD) with a Buy ...

Fintel reports that on April 7, 2025, HC Wainwright & Co. initiated coverage of Alto Neuroscience (NYSE:ANRO) with a Buy ...

Stock analysts at HC Wainwright boosted their Q3 2025 earnings per share (EPS) estimates for shares of Alnylam ...

Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for Ryvyl in a research report issued to clients and investors on Thursday, April 3rd. HC Wainwright analyst K. Dede ...

H.C. Wainwright lowered the firm’s price target on Bicara Therapeutics (BCAX) to $44 from $45 and keeps a Buy rating on the shares following ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $2.79, a high ...

H.C. Wainwright initiated coverage of Ionis Pharmaceuticals (IONS) with a Buy rating and $45 price target Ionis is a commercial-stage biotech ...

HC Wainwright initiates Ionis with Buy rating and $45 target, citing strong pipeline, solid revenue, and key clinical ...

American Rebel Holdings Inc. Forged in Freedom, Fueled by Growth, Focused on the Future Forged in Freedom, Fueled by Growth, ...

Vanda's strong financials and product lineup show promise, but management concerns and FDA disputes may hinder growth. Learn ...

DUBLIN, Ohio, April 07, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), a real ...

Forged in Freedom, Fueled by Growth, Focused on the Future NASHVILLE, TN, April 07, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), the creat ...